
Mohammad Omar Hussaini MD
Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology
Physician
Join to View Full Profile
660 S Euclid AveSaint Louis, MO 63110
Phone+1 314-362-1010
Fax+1 813-745-1708
Dr. Hussaini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Molecular Genetic Pathology, 2012 - 2013
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematopathology, 2011 - 2012
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2007 - 2011
- University of Illinois College of MedicineClass of 2006
- University of Illinois at ChicagoBA, 1998 - 2000
Certifications & Licensure
- FL State Medical License 2013 - 2027
- IL State Medical License 2022 - 2023
- MO State Medical License 2011 - 2014
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Awards, Honors, & Recognition
- University Scholars University of Illinois at Chicago, 2000
- University Scholars Award/Scholarship University of Illinois at Chicago, 1998
- National Dean’s List
Publications & Presentations
PubMed
- KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features.Farhan Hassan, Hailing Zhang, Dietrich Werner Idiaquez, Nagehan Pakasticali, Elizabeth Hyjek
American Journal of Clinical Pathology. 2025-05-26 - CD5-positive B-cell acute lymphoblastic leukemia/lymphoma with MEF2D::BCL9 mimicking aggressive mature B-cell lymphoma: a case report of a newly described entity and p...Dietrich Werner Idiaquez, Leidy L Isenalumhe, Elizabeth M Hyjek, Rohit Sharma, Hammad Tashkandi
Journal of Hematopathology. 2025-05-13 - CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma.Marco Davila, Sae Bom Lee, Yun Pyo Kang, Justin Boucher, Jay Mandula
Research Square. 2025-03-31
Journal Articles
- Sentinel case of richter transformation from chronic lymphocytic leukemia/small lymphocytic lymphoma to CD3+ diffuse large b-cell lymphomaIsmail, M; Mallick, J; Qin, D; Hussaini, M, Journal of Clinical Pathology, 1/1/2017
- PRDM1 expression levels in Marginal Zone Lymphoma and Lymphoplasmacytic LymphomaM Hussaini, C Yeung, XP Zhu, A Mirza, J Pfeifer, A Hassan, Int J Clin Exp Pathol, 1/1/2017
- Allogeneic hematopoietic cell transplantation for Richter syndrome: a single-center experienceMohamed A. Kharfan-Dabaja, Ambuj Kumar, Facundo Stingo, Farhad Khimani, Mohammad Hussaini, Ernesto Ayala, Taiga Nishihori, Bijal Shah, Frederick Locke, Javier Pinilla-..., Clinical Lymphoma, Myeloma and Leukemia, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- RUNX1 Mutation Is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia Receiving Allogeneic Stem Cell TransplantationMohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- CSF3R Mutations Are Exceedingly Rare Genetic Events Associated with Inferior Survival and Sensitivity to Ruxolitinib across Myeloid MalignanciesMohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell TherapyMohammad Hussaini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Moffitt Cancer Center 2-Year Single-Institution Experience with Next-Generation Sequencing Minimal Residual Disease Detection: Clinical Utility, Application, and Corre...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: